Bioventix (LON:BVXP) Releases Quarterly Earnings Results

Bioventix (LON:BVXP) issued its earnings results on Monday. The biotechnology company reported GBX 72.27 ($0.93) earnings per share for the quarter, Digital Look Earnings reports. Bioventix had a net margin of 59.51% and a return on equity of 69.09%.

Bioventix Stock Performance

Shares of LON:BVXP opened at GBX 2,440 ($31.54) on Wednesday. The firm has a market cap of £127.77 million, a price-to-earnings ratio of 15.78 and a beta of 0.35. The firm has a fifty day moving average price of GBX 2,879.90 and a 200 day moving average price of GBX 3,347.62. Bioventix has a fifty-two week low of GBX 2,355 ($30.45) and a fifty-two week high of GBX 4,800 ($62.06).

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.